The facility, Unit-VI, has been granted approval for Cefotaxime sodium for injection, Ceftriaxone sodium for injection and Cefuroxime sodium for injection, indiainfoline.com reported.
Following the approval, the company is likely to enter into 27 European Union member states, EEU, South Africa and Middle East markets.
The approval was granted following an inspection of the facility by the Hungarian Authority – National Institute for Quality and Organizational Development in Healthcare and Medicines, National Institute of Pharmacy.